IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MOHAMMED FAISAL ALI

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1205817335
CMS profile
100380
Location
ROCKVILLE CENTER, NY

General Payments · PY2018–2024

$44,153.91

  • Reported across 841 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$4,678.48

65 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Hematology & Oncology NY All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $2,387.50 2
Food and Beverage $1,291.02 51
Long term medical supply or device loan $999.96 12

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $1,418.65 3
NOVARTIS PHARMACEUTICALS CORPORATION $1,342.98 28
PFIZER INC. $1,032.38 3
Lilly USA, LLC $157.31 2
Exelixis Inc. $124.97 1
Stemline Therapeutics Inc. $57.52 2
E.R. Squibb & Sons, L.L.C. $53.38 3
GlaxoSmithKline, LLC. $50.84 2
Incyte Corporation $48.59 2
Mirati Therapeutics, Inc. $45.69 2
Merck Sharp & Dohme Corporation $43.94 2
Pharmacosmos Therapeutics Inc. $43.43 2
Genentech USA, Inc. $39.01 2
PUMA BIOTECHNOLOGY, INC. $34.36 2
Janssen Biotech, Inc. $26.93 1
SpringWorks Therapeutics, Inc. $24.51 1
Celgene Corporation $23.71 1
Agios Pharmaceuticals, Inc. $20.45 1
GENZYME CORPORATION $19.37 1
MENARINI SILICON BIOSYSTEMS, INC. $18.18 1
Sandoz Inc. $17.82 1
PharmaEssentia USA Corporation $17.72 1
ABBVIE INC. $16.74 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $9,493.99 163
PY2019 $4,041.50 130
PY2020 $2,900.33 68
PY2021 $9,209.15 159
PY2022 $8,665.62 151
PY2023 $5,164.84 105
PY2024 $4,678.48 65

Payment records · PY2024 (65)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $16.74 03/11/2024 Food and Beverage Undisputed 01/23/2026 1103203615 CMS
Agios Pharmaceuticals, Inc. $20.45 10/10/2024 Food and Beverage Undisputed 01/23/2026 1149641948 CMS
AstraZeneca Pharmaceuticals LP $24.46 01/29/2024 Food and Beverage Undisputed 01/23/2026 1105716440 CMS
AstraZeneca Pharmaceuticals LP $6.69 04/18/2024 Food and Beverage Undisputed 01/23/2026 1104251703 CMS
AstraZeneca Pharmaceuticals LP $1,387.50 08/02/2024 Consulting Fee Undisputed 01/23/2026 1105280128 CMS
Celgene Corporation $23.71 10/03/2024 Food and Beverage Undisputed 01/23/2026 1101163370 CMS
E.R. Squibb & Sons, L.L.C. $14.61 05/20/2024 Food and Beverage Undisputed 01/23/2026 1101616142 CMS
E.R. Squibb & Sons, L.L.C. $21.54 07/17/2024 Food and Beverage Undisputed 01/23/2026 1101616146 CMS
E.R. Squibb & Sons, L.L.C. $17.23 11/07/2024 Food and Beverage Undisputed 01/23/2026 1101616164 CMS
Exelixis Inc. $124.97 05/02/2024 Food and Beverage Undisputed 01/23/2026 1138562402 CMS
Genentech USA, Inc. $19.73 07/29/2024 Food and Beverage Undisputed 01/23/2026 1133074926 CMS
Genentech USA, Inc. $19.28 10/21/2024 Food and Beverage Undisputed 01/23/2026 1133074930 CMS
GENZYME CORPORATION $19.37 06/06/2024 Food and Beverage Undisputed 01/23/2026 1139624761 CMS
GlaxoSmithKline, LLC. $20.35 04/16/2024 Food and Beverage Undisputed 01/23/2026 1116253409 CMS
GlaxoSmithKline, LLC. $30.49 11/19/2024 Food and Beverage Undisputed 01/23/2026 1116510569 CMS
Incyte Corporation $25.17 08/12/2024 Food and Beverage Undisputed 01/23/2026 1141249590 CMS
Incyte Corporation $23.42 09/16/2024 Food and Beverage Undisputed 01/23/2026 1141276414 CMS
Janssen Biotech, Inc. $26.93 10/31/2024 Food and Beverage Undisputed 01/23/2026 1078481025 CMS
Lilly USA, LLC $124.99 05/16/2024 Food and Beverage Undisputed 01/23/2026 1135219532 CMS
Lilly USA, LLC $32.32 08/19/2024 Food and Beverage Undisputed 01/23/2026 1135202810 CMS
Menarini Silicon Biosystems, Inc. $18.18 04/25/2024 Food and Beverage Undisputed 01/23/2026 1099887140 CMS
Merck Sharp & Dohme LLC $27.28 07/15/2024 Food and Beverage Undisputed 01/23/2026 1141653759 CMS
Merck Sharp & Dohme LLC $16.66 08/15/2024 Food and Beverage Undisputed 01/23/2026 1141653747 CMS
Mirati Therapeutics, Inc. $20.82 03/25/2024 Food and Beverage Undisputed 01/23/2026 1117173415 CMS
Mirati Therapeutics, Inc. $24.87 10/14/2024 Food and Beverage Undisputed 01/23/2026 1117173411 CMS
Novartis Pharmaceuticals Corporation $22.10 01/08/2024 Food and Beverage Undisputed 01/23/2026 1086622097 CMS
Novartis Pharmaceuticals Corporation $83.33 01/18/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086622127 CMS
Novartis Pharmaceuticals Corporation $22.13 02/12/2024 Food and Beverage Undisputed 01/23/2026 1086622103 CMS
Novartis Pharmaceuticals Corporation $83.33 02/16/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086622129 CMS
Novartis Pharmaceuticals Corporation $15.92 03/07/2024 Food and Beverage Undisputed 01/23/2026 1086622105 CMS
Novartis Pharmaceuticals Corporation $83.33 03/15/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086622131 CMS
Novartis Pharmaceuticals Corporation $24.17 03/20/2024 Food and Beverage Undisputed 01/23/2026 1086622107 CMS
Novartis Pharmaceuticals Corporation $18.63 04/11/2024 Food and Beverage Undisputed 01/23/2026 1086622109 CMS
Novartis Pharmaceuticals Corporation $83.33 04/18/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086622133 CMS
Novartis Pharmaceuticals Corporation $23.17 05/09/2024 Food and Beverage Undisputed 01/23/2026 1086622111 CMS
Novartis Pharmaceuticals Corporation $11.93 05/14/2024 Food and Beverage Undisputed 01/23/2026 1086622115 CMS
Novartis Pharmaceuticals Corporation $83.33 05/16/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086622135 CMS
Novartis Pharmaceuticals Corporation $83.33 06/13/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086622137 CMS
Novartis Pharmaceuticals Corporation $22.77 07/02/2024 Food and Beverage Undisputed 01/23/2026 1086622119 CMS
Novartis Pharmaceuticals Corporation $83.33 07/15/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086622139 CMS
Novartis Pharmaceuticals Corporation $83.33 08/23/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086622123 CMS
Novartis Pharmaceuticals Corporation $23.54 09/18/2024 Food and Beverage Undisputed 01/23/2026 1086622141 CMS
Novartis Pharmaceuticals Corporation $9.88 09/19/2024 Food and Beverage Undisputed 01/23/2026 1086622149 CMS
Novartis Pharmaceuticals Corporation $83.33 09/27/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086622125 CMS
Novartis Pharmaceuticals Corporation $25.93 10/02/2024 Food and Beverage Undisputed 01/23/2026 1086622151 CMS
Novartis Pharmaceuticals Corporation $83.33 10/17/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086622147 CMS
Novartis Pharmaceuticals Corporation $19.70 10/22/2024 Food and Beverage Undisputed 01/23/2026 1086622155 CMS
Novartis Pharmaceuticals Corporation $27.15 10/24/2024 Food and Beverage Undisputed 01/23/2026 1086622157 CMS
Novartis Pharmaceuticals Corporation $25.11 11/11/2024 Food and Beverage Undisputed 01/23/2026 1086622159 CMS
Novartis Pharmaceuticals Corporation $83.33 11/14/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086622145 CMS
Novartis Pharmaceuticals Corporation $24.82 11/25/2024 Food and Beverage Undisputed 01/23/2026 1086622153 CMS
Novartis Pharmaceuticals Corporation $26.07 11/26/2024 Food and Beverage Undisputed 01/23/2026 1086622161 CMS
Novartis Pharmaceuticals Corporation $83.33 12/10/2024 Long term medical supply or device loan Undisputed 01/23/2026 1086622163 CMS
PFIZER INC. $1,000.00 03/01/2024 Consulting Fee Undisputed 01/23/2026 1131586160 CMS
PFIZER INC. $6.40 03/13/2024 Food and Beverage Undisputed 01/23/2026 1131294757 CMS
PFIZER INC. $25.98 03/26/2024 Food and Beverage Undisputed 01/23/2026 1131269680 CMS
Pharmacosmos Therapeutics Inc. $23.27 04/15/2024 Food and Beverage Undisputed 01/23/2026 1154819593 CMS
Pharmacosmos Therapeutics Inc. $20.16 09/26/2024 Food and Beverage Undisputed 01/23/2026 1154819595 CMS
PharmaEssentia USA Corporation $17.72 06/13/2024 Food and Beverage Undisputed 01/23/2026 1137305733 CMS
PUMA BIOTECHNOLOGY, INC. $18.57 04/29/2024 Food and Beverage Undisputed 01/23/2026 1113852448 CMS
PUMA BIOTECHNOLOGY, INC. $15.79 07/25/2024 Food and Beverage Undisputed 01/23/2026 1113850419 CMS
Sandoz Inc. $17.82 12/10/2024 Food and Beverage Undisputed 01/23/2026 1089364893 CMS
SpringWorks Therapeutics, Inc. $24.51 09/30/2024 Food and Beverage Undisputed 01/23/2026 1085802526 CMS
Stemline Therapeutics Inc. $32.70 05/10/2024 Food and Beverage Undisputed 01/23/2026 1142962353 CMS
Stemline Therapeutics Inc. $24.82 06/24/2024 Food and Beverage Undisputed 01/23/2026 1142962351 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.